Valuation-related aspects of consolidated financial statements
Why valuation matters in consolidated financial statements
Ensuring compliance and audit-oriented readiness
Valuation-related matters such as purchase price allocations, impairment testing, and investment valuations play a critical role in consolidated financial statements. These processes are essential for the accurate presentation of assets and for ensuring compliance with HGB, IFRS and US GAAP requirements.
finsus advisory supports organizations in managing complex valuation processes professionally and in an audit-oriented manner, helping them meet all relevant accounting and regulatory requirements within the financial reporting framework.
Purchase price allocations (PPA)
Accurate valuation of assets
Following a business combination, the acquired assets and liabilities must be remeasured and recognized as part of a purchase price allocation (PPA) within the consolidated financial statements.
In practice, this process involves not only the valuation of existing assets and liabilities but also the identification and valuation of additional assets and obligations that may not have been previously recognized.
This process is commonly referred to as a purchase price allocation (PPA). finsus advisory supports clients in identifying and valuing acquired assets and liabilities – ranging from intangible assets, such as trademarks and customer relationships, to property, plant and equipment and contingent liabilities.
PPA at a glance
01
What is the objective of a PPA?
01
Remeasurement of all acquired assets and liabilities at fair value
02
What is subject to valuation?
02
In addition to recognized assets and liabilities, particular focus is placed on trademarks, patents, technologies, and customer relationships
03
How is it implemented?
03
In accordance with HGB requirements in Germany and IFRS and US GAAP requirements internationally
04
How are the results documented?
04
Through comprehensive, audit-oriented documentation of the PPA results
Advisory services tailored to your needs
finsus advisory adapts to your specific requirements
Impairment Test
Assessing the recoverability of assets and cash-generating units
An impairment, or decline in value, refers to an unforeseen reduction in the value of an asset. An impairment test is performed to determine whether individual assets require a write-down as of the reporting date due to such a decline in value.
The objective of the impairment test is to assess whether the carrying amount of an asset or a cash-generating unit (CGU) exceeds its recoverable amount as defined under IFRS. The ultimate goal is to ensure that assets are carried at values that remain recoverable.
finsus advisory supports organizations in performing impairment tests and documenting the results in an audit-oriented manner. We also provide expert guidance on impairment-related matters within the context of US GAAP or HGB financial statements.
Do you have questions about valuation matters? I would be pleased to assist you and answer your questions.
Dr. Andreas Cebul
Contact

HFA 10: valuation of investments under German accounting standards
The HFA 10 guidance issued by the Institute of Public Auditors in Germany (IDW) provides the framework for the valuation of equity investments recognized in the balance sheet under German accounting standards.
finsus advisory supports organizations in applying these requirements correctly, helping to minimize accounting risks and ensure transparent, compliant, and audit-ready investment valuations.
